Vitamin D Replacement in Statin-Induced Myopathy

HMG COA Reductase Inhibitor Adverse Reaction Clinical Trial

Official title: Vitamin D Replacement in Statin-Induced Myopathy

Status Withdrawn

Clinical Trial Summary

Pretreating people with replacement doses of vitamin D will allow them to tolerate Statin medications that have caused muscle pain for them in the past.

Clinical Trial Description

Patients who have been unable to tolerate statin medications due to muscle pain will be randomly assigned to receive vitamin D or placebo for 6 weeks before reintroducing their statin medication. The investigators will judge whether vitamin D in the manner administered in the study reduces the myalgia with statins and allows patients to remain on these important medications. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• HMG COA Reductase Inhibitor Adverse Reaction

• NCT number: NCT01400009
• Study type: Interventional
• Source: McGill University Health Center
• Status: Withdrawn
• Phase: N/A
• Start date: October 2010
• Completion date: July 2012